Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury
Condition: Muscle Injury Interventions: Other: Electrical stimulation; Other: Growth hormone (somatropin); Other: Control (No electrical stimulation, nor growth hormone) Sponsor: Bispebjerg Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2023 Category: Research Source Type: clinical trials
Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury
Condition: Muscle Injury Interventions: Procedure: Electrical stimulation; Drug: Growth hormone (somatropin); Other: Control (No electrical stimulation, nor growth hormone) Sponsor: Bispebjerg Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2023 Category: Research Source Type: clinical trials
Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury
Condition: Muscle Injury Interventions: Other: Electrical stimulation; Other: Growth hormone (somatropin); Other: Control (No electrical stimulation, nor growth hormone) Sponsor: Bispebjerg Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2023 Category: Research Source Type: clinical trials
A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome
Condition: Turner Syndrome Interventions: Biological: Lonapegsomatropin; Drug: Somatropin Sponsor: Ascendis Pharma Endocrinology Division A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2023 Category: Research Source Type: clinical trials
A Multicenter, Phase 2, Randomized, Open-label, Active-controlled, Parallel Group Clinical Trial to Investigate the Safety, Tolerability, and Efficacy of Different Dose Levels of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Individuals With Turner Syndrome
Condition: Turner Syndrome Interventions: Biological: Lonapegsomatropin; Device: Somatropin Sponsor: Ascendis Pharma Endocrinology Division A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2023 Category: Research Source Type: clinical trials